Malignant and Benign Peripheral Nerve Sheath Tumors in a Single Center
Authors:
- 29 September 2023
- journal article
- research article
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 43 (1) , 21-31
Abstract
Objectives: This study aimed to investigate the combined use of ultrasonography and clinical features for the differentiation of malignant peripheral nerve sheath tumors (MPNST) from benign peripheral nerve sheath tumors (BPNST) and to compare the efficacy of ultrasonography with that of magnetic resonance imaging (MRI).Methods: This retrospective study included 28 MPNSTs and a control group of 57 BPNSTs. All patients underwent an ultrasound scan using the Logiq E9 (GE Health Care, Milwaukee, WI) or EPIQ7 equipment (Philips Medical System, Bothell, WA). A 3.0‐T MRI machine (Ingenia; Philips Healthcare, Best, the Netherlands) was used for scanning, and conventional MRI was performed on different regions based on the patient's clinical situation. The following variables were evaluated: palpable mass, pain, nerve symptoms, maximum diameter, location, shape, boundary, encapsulation, echogenicity, echo homogeneity, presence of a cystic component, calcification, target sign, posterior echo, and intertumoral vascularity of the tumors. The diagnostic efficacy of ultrasonography and clinical factors was compared with that of MRI. Independent factors for predicting MPNST versus BPNST were also assessed.Results: The parameters of location, shape, boundary, encapsulation, and vascularity were significantly different between MPNSTs and BPNSTs. Multiple logistic regression analysis showed that shape, boundary, and vascularity were independent predictors of MPNSTs. The sensitivity, specificity, and Youden index of the three clinical and ultrasound factors (shape, boundary, and vascularity) were 0.89, 0.81, and 0.69, respectively, whereas those of MRI were 0.71, 0.89, and 0.61, respectively. No significant differences in the area under the curve (AUC) of the three combined clinical and ultrasound factors and those of MRI were found (P > .05).Conclusions: MRI was useful in the differential diagnosis between MPNSTs and BPNSTs. However, the combination of clinical and ultrasound diagnoses can achieve the same effect as MRI, including shape, boundary, and vasculature.Keywords
This publication has 22 references indexed in Scilit:
- Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1–associated, and radiation-associated malignant peripheral nerve sheath tumorsJournal of Neurosurgery, 2017
- Malignant Peripheral Nerve Sheath TumorSurgical Oncology Clinics of North America, 2016
- Imaging of the malignant peripheral nerve sheath tumour with emphasis οn ultrasonography: correlation with MRIJournal of Ultrasound, 2014
- Malignant Peripheral Nerve Sheath TumorsThe Oncologist, 2014
- Comparative Effectiveness of 18F-FDG PET/CT Versus Whole-Body MRI for Detection of Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1Clinical Nuclear Medicine, 2013
- Differentiation of soft tissue benign and malignant peripheral nerve sheath tumors with magnetic resonance imagingClinical Imaging, 2008
- A 10-Year Review of Benign and Malignant Peripheral Nerve Sheath Tumors in a Single Center: Clinical and Radiographic Features Can Help to Differentiate Benign from Malignant LesionsPlastic and Reconstructive Surgery, 2008
- Sonographic Characteristics of Peripheral Nerve Sheath TumorsAmerican Journal of Roentgenology, 2004
- Interaction of plasminogen-related protein B with endothelial and smooth muscle cells in vitroExperimental Cell Research, 2003
- Doppler ultrasound color flow imaging in the study of breast cancer: Preliminary findingsUltrasound in Medicine & Biology, 1990